To further evaluate whether NF-κB signaling pathway is responsible for NSCLC cell migration and invasion regulated by Id-1, we performed rescue experiments by treatment with NF-κB activator TNF-α and NF-κB translocation inhibitor JSH-23. The gene discussed is ID1; the disease is non-small cell lung carcinoma.